茶叶科学 ›› 2010, Vol. 30 ›› Issue (6): 414-422.doi: 10.13305/j.cnki.jts.2010.06.002
顾成波1,2,5, 袁肖寒3,4, 付玉杰1,2, 祖元刚1,2,*, 赵恩泽1,2, 李旺1,2, 王秋雪1,2
收稿日期:
2010-01-06
修回日期:
2010-03-11
发布日期:
2019-09-11
通讯作者:
zygorl@yahoo.com.cn
作者简介:
顾成波(1975— ),男,黑龙江哈尔滨人,讲师,主要从事药用植物活性成分提取分离及其药理作用研究。
基金资助:
GU Cheng-bo1,2,5, YUAN Xiao-han3,4, FU Yu-jie1,2, ZU Yuan-gang1,2,*, ZHAO En-ze1,2, LI Wang1,2, WANG Qiu-xue1,2
Received:
2010-01-06
Revised:
2010-03-11
Published:
2019-09-11
摘要: 表没食子儿茶素没食子酸酯(EGCG)是绿茶中含量最高、活性最强的多酚类成分。近年来绿茶EGCG癌症预防作用的分子靶点一直备受关注。本文对已报道的EGCG癌症预防作用机制及其可能的作用靶点进行了综述,讨论了将EGCG开发为癌症化学预防剂应采取的策略,以期为设计预防癌症的新方案提供借鉴。
中图分类号:
顾成波, 袁肖寒, 付玉杰, 祖元刚, 赵恩泽, 李旺, 王秋雪. 绿茶EGCG防癌作用的分子靶点[J]. 茶叶科学, 2010, 30(6): 414-422. doi: 10.13305/j.cnki.jts.2010.06.002.
GU Cheng-bo, YUAN Xiao-han, FU Yu-jie, ZU Yuan-gang, ZHAO En-ze, LI Wang, WANG Qiu-xue. Molecular Targets for Cancer Chemoprevention by (-)-Epigallocatechin Gallate of Green Tea[J]. Journal of Tea Science, 2010, 30(6): 414-422. doi: 10.13305/j.cnki.jts.2010.06.002.
[1] Naghma Khan, Farrukh Afaq, Mohammad Saleem, [2] Yang CS, Maliakal P, Meng X.Inhibition of carcinogenesis by tea[J]. Annu Rev Pharmacol Toxicol, 2002(42): 25-54. [3] Yang CS, Sang S, Lambert JD, [4] Park OJ, Surh YJ.Chemopreventive potential of epigallocatechin gallate and genistein: evidence from epidemiological and laboratory studies[J]. Toxicol Lett, 2004, 150(1): 43-56. [5] Yang CS, Wang X, Lu G, [6] Moyers SB, Kumar NB.Green tea polyphenols and cancer chemoprevention: multiple mechanisms and endpoints for phase II trials. Nutr Rev 2004, 62(5):204-211. [7] Yang CS, Landau JM, Huang MT, [8] Bettuzzi S, Brausi M, Rizzi F, [9] Nagle DG, Ferreira D, Zhou YD.Epigallocatechin-3-gallate (EGCG): Chemical and biomedical perspectives[J]. Phytochemistry. 2006, 67(17): 1849-1855. [10] Tachibana H, Koga K, Fujimura Y, [11] Leone M, Zhai D, Sareth S, [12] Ermakova S, Choi BY, Choi, [13] Katiyar SK, Afaq F, Azizuddin K, [14] Maeda-Yamamoto M, Suzuki N, Sawai Y, [15] Chung JY, Huang C, Meng X.Inhibition of activator protein 1 activity and cell growth by purified green tea polyphones and black tea polyphenols in H-ras-transformed cells:structure-activity relationship and mechanism involved[J]. Cancer Res, 1999, 59(18): 4610-4617. [16] Hou Z, Lambert JD, Chin KV, [17] Surh YJ, Chun KS, Cha HH. Molecular mechanisms underlying chemoprevention activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappaB activation[J]. Mutat Res, 2001, 480/481: 243-268. [18] Dong Z, Ma W, Huang C, [19] Huang C, Ma WY, Hanenberger D, [20] Liang YC, Lin-Shiau SY, Chen CF, [21] Liang YC, Lin-Shiau SY, Chen CF, [22] Sah JF, Balasubramanian S, Eckert RL, [23] Masuda M, Suzui M, Lim JT, [24] Masuda M, Suzui M, Weinstein IB.Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines[J]. Clin Cancer Res, 2001, 7(12): 4220-4229. [25] Shimizu M, Deguchi A, Lim JT, [26] Naasani I, Oh-Hara F, Oh-Hara T, [27] Naasani I, Seimiya H, TsuruoT. Telomerase inhibition, telomere shortening, and senescence of cancer cells by tea catechins[J]. Biochem Biophys Res Commun, 1998, 249(2): 391-396. [28] Fang MZ, Wang Y, Ai N, [29] Navarro-Perán E, Cabezas-Herrera J, García-Cánovas F, [30] Montagut C, Rovira A, Albanell J.The proteasome: anovel target for anticancer therapy[J]. Clin Transl Oncol, 2006, 8(5):313-317. [31] Nam S, Smith DM, Dou QP.Ester bond-containing tea polyphenols potently inhibit proteasome activity [32] Li M, He Z, Ermakova S, [33] He ZW, Tang F, Ermakova S, [34] Ermakova SP, Bong SK, Bu YC, [35] Shim JH, Choi HS, Pugliese A, [36] Konstantinopoulos PA, Karamouzis MV, Papatsoris AG, [37] Zhen MC, Huang XH, Wang Q, [38] Fassina G, Vene R, Morini M, [39] Ho YC, Yang SF, Peng CY, [40] Berger S J, Gupta S, Belfi CA, [41] Hayakawa S, Saeki K, Sazuka M, [42] Brusselmans K, De Schrijver E, Heyns W, [43] Jung YD, Kim MS, Shin BA, [44] Jankun J, Selman SH, Swiercz R, [45] Yoshizawa S, Horiuchi T, Fujiki H, [46] Gupta S, Hastak K, Ahmad N, [47] AdhamiVM, Siddiqui IA, AhmadN, et al. Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer[J]. Cancer Res, 2004, 64(23): 8715-8722. [48] Vayalil PK, Elmets CA, Katiyar SK.Treatment of green tea polyphenols in hydrophilic cream prevents UVB-induced oxidation of lipids and proteins, depletion of antioxidant enzymes and phosphorylation of MAPK proteins in SKH-1 hairless mouse skin[J]. Carcinogenesis, 2003 24(5): 927-936. [49] Liao J, Yang GY, Park ES, [50] Ju J, Hong J, Zhou JN, 1)gallate, the major catechin in green tea[J]. Cancer Res, 2005, 65(22): 10623-10631. [51] Umeda D, Yano S, Yamada K, [52] Ahn WS, Yoo J, Huh SW, [53] Jatoi A, Ellison N, Burch PA, [54] Fujiki H.Two stages of cancer prevention with green tea[J]. J Cancer Res Clin Oncol, 1999, 125(11): 589-597. [55] Lee WJ, Shim JY, Zhu BT, [56] Abe I, Seki T, Umehara K, [57] Lamy S, Gingras D, Beliveau R.Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation[J]. Cancer Res, 2002, 62(2): 381-385. [58] U Ullmann, J Haller, JP Decourt, [59] RA Isbrucker, JA Edwards, E Wolz, [60] Chung S Y, Joshua DL, Zhe H, [61] Li L,Chan TH.Enantioselective synthesis of EGCG, the active polyphenol component from green tea[J]. Org Lett, 2001, 3(5): 739-741. [62] Surh YJ.Cancer chemoprevention with dietary phytochemicals[J]. Nature Reviews Cancer, 2003, 3(10): 768-780. [63] Pisters KM, Newman RA, Coldman B, [64] Shanafelt T D, Call T, Zent C S, [65] Shanafelt T D, Call T, Zent C S, [66] Joshua D Lambert, Shengmin Sang, Chung S Yang.Possible controversy over dietary polyphenols: benefits vs risks[J]. Chem Res Toxicol, 2007, 20(4): 583-585. [67] Yang CS, Lambert JD, Sang S.Antioxidative and anti-carcinogenic activities of tea polyphenols[J]. Arch Toxicol, 2009, 83(1): 11-21. |
[1] | 陈珂, 王苑竹, 杨晓颖, 张冬英, 朱强强. 壳聚糖复合β-乳球蛋白负载EGCG纳米粒的制备及其对糖尿病小鼠血糖的影响[J]. 茶叶科学, 2022, 42(5): 731-739. |
[2] | 俞蓉欣, 郑芹芹, 陈红平, 张劲松, 张相春. 儿茶素生物医用纳米材料研究进展[J]. 茶叶科学, 2022, 42(4): 447-462. |
[3] | 张旖旎, 吉铮. 表没食子儿茶素没食子酸酯(EGCG)研究的文献计量分析[J]. 茶叶科学, 2022, 42(3): 423-434. |
[4] | 张建勇, 陈琳, 崔宏春, 王伟伟, 薛金金, 熊春华, 江和源. PBD和RSM联用优化聚酯型儿茶素A化学合成技术参数[J]. 茶叶科学, 2020, 40(1): 51-62. |
[5] | 徐佳佳, 广敏, 史书林, 郜红建. 茶树根系跨膜吸收氟的生理与分子机制[J]. 茶叶科学, 2019, 39(4): 365-371. |
[6] | 孙丽丽, 曾祥泉, NileshWGaikwad, 王欢, 须海荣, 叶俭慧. 绿茶儿茶素类生物标记物的检测及应用[J]. 茶叶科学, 2017, 37(5): 429-441. |
[7] | 黄翔翔, 杨哲, 禹利君. 绿茶、EGCG预防及缓解香烟烟雾诱导COPD的研究进展[J]. 茶叶科学, 2017, 37(4): 332-338. |
[8] | 祁洁, 徐颖磊, 梁文怡, 费朵, 乌昕儿, 金建昌, 杜琪珍, 许勇泉, 高颖. EGCG纳米载体制备技术及其对EGCG活性影响的研究进展[J]. 茶叶科学, 2017, 37(2): 119-129. |
[9] | 张静, 黄建安, 蔡淑娴, 易晓芹, 刘建军, 王英姿, 田丽丽, 刘仲华. 茶黄素与EGCG抑制体内外β-淀粉样蛋白1-42水平及其诱导的神经细胞氧化损伤[J]. 茶叶科学, 2016, 36(6): 655-662. |
[10] | 柳敏, 饶国武, 华允芬. EGCG衍生物合成及药理活性研究进展[J]. 茶叶科学, 2016, 36(2): 119-130. |
[11] | 叶晓锋, 张芳, 朱军莉, 张蕾, 谢杜梅. EGCG抑制波罗的海希瓦氏菌生物被膜和腐败活性的研究[J]. 茶叶科学, 2016, 36(2): 201-209. |
[12] | 孟庆, 屠幼英. TF1与EGCG在Caco-2细胞中的吸收规律研究[J]. 茶叶科学, 2015, 35(3): 233-238. |
[13] | 高媛圆, 毛立民, 徐平, 王岳飞. 茶多酚防治2型糖尿病的分子机理研究进展[J]. 茶叶科学, 2015, 35(3): 239-247. |
[14] | 刘美雅, 伊晓云, 石元值, 马立锋, 阮建云. 茶园土壤性状及茶树营养元素吸收、转运机制研究进展[J]. 茶叶科学, 2015, 35(2): 110-120. |
[15] | 陈怡君, 熊立瑰, 黄建安, 龚雨顺, 刘仲华. EGCG对细胞的促氧化作用研究进展[J]. 茶叶科学, 2015, 35(2): 130-136. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||
|